Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Wenbin Lin
University of Chicago, Department: Chemistry
Should you be removed from our database? Contact us at [email protected]. Read more below.
RiMO Therapeutics, LLC
Intellectual property rights (e.g., royalties, patents, copyrights) not from the awardee Institution
The University of Chicago has elected to license intellectual property Dr. Lin has developed with the patent filing of "Nanoparticles for Photodynamic Therapy, X-Ray Induced Photodynamic Therapy Radiotherapy, Chemotherapy, Immunotherapy and any Combination Thereof" to RiMo Therapeutics, LLC. Dr. Lin is the founder of RiMo Therapeutics, LLC, which will attempt to further develop and commercialize the IP. the IP figures centrally into the funded project 1U01CA198989 (Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers).
Nanoscale Metal-organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancers
Combinations of radiation therapy and chemotherapy are currently the most common curative treatments for HNSCC, which cause many undesirable side effects. We propose to develop novel nanoscale metal-organic frameworks (NMOFs) as highly efficient and safe PDT agents that will not only enhance the efficacy of light- activated PDT treatment of superficial tumors but also enable efficient X-ray induced PDT treatment of deep tumors. The therapeutic modality to be established in this project will herald a new paradigm for the treatment of HNSCC and other cancers that do not respond to traditional radiotherapy or chemotherapy.
Filed on October 29, 2015.
Tell us what you know about Wenbin Lin's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Wenbin Lin filed other conflict of interest disclosures with the NIH:
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Wenbin Lin | University of Chicago | Conflict of Interest | Intellectual Property: Frameworks for light-triggered and Xray induced photodynamic therapy | Value cannot be readily determined |
| Wenbin Lin | University of Chicago | Conflict of Interest | Intellectual Property: Frameworks for light-triggered and Xray induced photodynamic therapy | Value cannot be readily determined |
| Wenbin Lin | University of Chicago | Conflict of Interest | Coordination Pharmaceuticals, Inc. | Value cannot be readily determined |
| Wenbin Lin | University of Chicago | Conflict of Interest | Coordination Pharmaceuticals | Value cannot be readily determined |
| Wenbin Lin | University of Chicago | Conflict of Interest | RiMO Therapeutics, LLC | Value cannot be readily determined |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.